Skip to content

The Clinical Trial of Stellate Ganglion Phototherapy for treatment of premature ventricular contraction.

The Clinical Trial for the Efficacy and Safety of Stellate Ganglion Phototherapy for treatment of premature ventricular contraction.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-jRCTs032220170
Enrollment
60
Registered
2022-06-30
Start date
2022-08-17
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

premature ventricular contraction

Interventions

The total of 10 minites stellate ganglion phototherapy with super lizer mini was performed every day at home for two weeks.

Sponsors

Komatsu Yuki
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1) Diagnosed with premature ventricular contraction (PVC), (2) The frequency of the PVC was over 5,000 beats per day in the holter electrocardiography in 3 months before on the obtaing consent, (3) Understanding the appropriate use of super lizer mini, (4) Aged 18 to 80 on the obtaing consent, (5) Obtained written the informed consent, (6) Out patient.

Exclusion criteria

Exclusion criteria: (1) Diagnosed with photosensitivity disorder, (2) Low ejection fraction (under 40%) or moderate or severe valvular disease was recognized with transthoracic echocardiography in 6 months before on the obtaing consent, (3) Perceptual disorder at neck due to uncontrolled severe diabetes mellitus, (4) Uncontrolled hypertension or unstable ischemic heart disease, (5) Adjudicated inappropriate by principal investigator.

Design outcomes

Primary

MeasureTime frame
The trend of the frequency of premature ventricular contraction per day between before stellate ganglion phototherapy and after.

Secondary

MeasureTime frame
The morphology of premature ventricular contraction, daily trend of premature ventricular contraction,the trend of the heart rate and symptoms such as palpitation, fatigue or discomfort in chest between before stellate ganglion phototherapy and after and the presence of skin disorders.

Contacts

Public ContactYuka Oda

University of Tsukuba Hospital

mashimo.yuka.0414@gmail.com+81-29-853-3143

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026